Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling

References

• Conway G S. Polycystic ovary syndrome: clinical aspects. Baillieres Clin Endocrinol Metab 1996; 10: 263–279
   PubMedGoogle Scholar
• Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–861
   PubMed Web of Science ®Google Scholar
• Hull M G. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1987; 1: 235–245
   PubMedGoogle Scholar
• Homburg R. Polycystic ovary syndrome: induction of ovulation. Baillieres Clin Endocrinol Metab 1996; 10: 281–292
   PubMedGoogle Scholar
• The ESHRE Capri Workshop. Female infertility: treatment options for complicated cases. European Society for Human Reproduction and Embryology. Hum Reprod 1997; 12: 1191–1196
   PubMed Web of Science ®Google Scholar
• Naether O G, Baukloh V, Fischer R, Kowalczyk T. Long-term follow-up in 206 infertility patients with polycystic ovarian syndrome after laparoscopic electrocautery of the ovarian surface. Hum Reprod 1994; 9: 2342–2349
   PubMed Web of Science ®Google Scholar
• Pelosi M A, Pelosi M A, 3rd. Laparoscopic electrosurgical furrowing technique for the treatment of polycystic ovaries. J Am Assoc Gynecol Laparosc 1996; 4: 57–62
   Google Scholar
• Weerakiet S, Srisombut C, Choktanasiri W, Rojanasakul A. Efficacy of laparoscopic ovulation induction in polycystic ovary syndrome. J Med Assoc Thai 1999; 82: 760–764
   PubMedGoogle Scholar
• Donesky B W, Adashi E Y. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril 1995; 63: 439–463
   PubMed Web of Science ®Google Scholar
• Dabirashrafi H. Complications of laparoscopic ovarian cauterization. Fertil Steril 1989; 52: 878–879
   PubMedGoogle Scholar
• Tozer A J, Al-Shawaf T, Zosmer A, Hussain S, Wilson C, Lower A M, Grudzinskas J G. Does laparoscopic ovarian diathermy affect the outcome of IVF–embryo transfer in women with polycystic ovarian syndrome? A retrospective comparative study. Hum Reprod 2001; 16: 91–95
   PubMed Web of Science ®Google Scholar
• Colacurci N, Zullo F, De Franciscis P, Mollo A, De Placido G. In vitro fertilization following laparoscopic ovarian diathermy in patients with polycystic ovarian syndrome. Acta Obstet Gynecol Scand 1997; 76: 555–558
   PubMed Web of Science ®Google Scholar
• Amer S A, Laird S, Ledger W L, Li T C. Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome. Hum Reprod 2007; 22: 389–394
   Google Scholar
• Kandil M, Selim M. Hormonal and sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome. Br J Obstet Gynaecol 2005; 112: 1427–1430
   Google Scholar
• Themmen A P. Anti-Mullerian hormone: its role in follicular growth initiation and survival and as an ovarian reserve marker. J Natl Cancer Inst Monogr 2005; 34: 18–21
   Google Scholar
• Gruijters M J, Visser J A, Durlinger A L, Themmen A P. Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003; 211: 85–90
   PubMed Web of Science ®Google Scholar
• Ficicioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimullerian hormone as an indicator of ovarian reserve. Fertil Steril 2006; 85: 592–596
   PubMed Web of Science ®Google Scholar
• Visser J A, de Jong F H, Laven J S, Themmen A P. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 2006; 131: 1–9
   PubMed Web of Science ®Google Scholar
• Pepinsky R B, Sinclair L K, Chow E P, Mattaliano R J, Manganaro T F, Donahoe P K, Cate R L. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-β-like fragment. J Biol Chem 1988; 263: 18961–18964
   PubMed Web of Science ®Google Scholar
• Vigier B, Picard J Y, Tran D, Legeai L, Josso N. Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 1984; 114: 1315–1320
   PubMed Web of Science ®Google Scholar
• Fanchin R, Schonauer L M, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 2003; 18: 323–327
   PubMed Web of Science ®Google Scholar
• Hazout A, Bouchard P, Seifer D B, Aussage P, Junca A M, Cohen-Bacrie P. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 2004; 82: 1323–1329
   PubMed Web of Science ®Google Scholar
• Seifer D B, MacLaughlin D T, Christian B P, Feng B, Shelden R M. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002; 77: 468–471
   PubMed Web of Science ®Google Scholar
• Balen A H, Conway G S, Kaltsas G, Techatrasak K, Manning P J, West C, Jacobs H S. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995; 10: 2107–2111
   PubMed Web of Science ®Google Scholar
• Ferriman D, Gallwey J D. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440–1447
   PubMed Web of Science ®Google Scholar
• Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689
   PubMed Web of Science ®Google Scholar
• Munro B H. Selected nonparametric techniques. Statistical methods for health care reserve5th ed, B H Munro. Lippincott Williams & Wilkins, Philadelphia, PA 2005; 109–135
   Google Scholar
• te Velde E R, Pearson P L. The variability of female reproductive ageing. Hum Reprod Update 2002; 8: 141–154
   PubMed Web of Science ®Google Scholar
• Somigliana E, Ragni G, Infantino M, Benedetti F, Arnoldi M, Crosignani P G. Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve?. Acta Obstet Gynecol Scand 2006; 85: 74–77
   PubMed Web of Science ®Google Scholar
• Lockwood G M, Muttukrishna S, Groome N P, Matthews D R, Ledger W L. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle. J Clin Endocrinol Metab 1998; 83: 1730–1735
   PubMed Web of Science ®Google Scholar
• van Rooij I A, Broekmans F J, Scheffer G J, Looman C W, Habbema J D, de Jong F H, Fauser B J, Themmen A P, te Velde E R. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005; 83: 979–987
   PubMed Web of Science ®Google Scholar
• Gjonnaess H. Late endocrine effects of ovarian electrocautery in women with polycystic ovary syndrome. Fertil Steril 1998; 69: 697–701
   PubMed Web of Science ®Google Scholar
• Amer S A, Gopalan V, Li T C, Ledger W L, Cooke I D. Long term follow-up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome. Hum Reprod 2002; 17: 2035–2042
   PubMed Web of Science ®Google Scholar
• Jonard S, Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004; 10: 107–117
   PubMed Web of Science ®Google Scholar
• Scheffer G J, Broekmans F J, Looman C W, Blankenstein M, Fauser B C, teJong F H, teVelde E R. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 2003; 18: 700–706
   PubMed Web of Science ®Google Scholar
• Scheffer G J, Broekmans F J, Dorland M, Habbema J D, Looman C W, te Velde E R. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 1999; 72: 845–851
   PubMed Web of Science ®Google Scholar
• Webber L J, Stubbs S, Stark J, Trew G H, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003; 362: 1017–1021
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88: 5957–5962
   PubMed Web of Science ®Google Scholar
• Chu M C, Carmina E, Wang J, Lobo R A. Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertil Steril 2005; 84: 1685–1688
   PubMed Web of Science ®Google Scholar
• Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen J S. Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Hum Reprod 2005; 20: 1820–1826
   PubMed Web of Science ®Google Scholar
• Cohen J. Statistical power analysis for behavioral sciences2nd ed. Lawrence Erlbaum Associates, Publishers, Hillsdale, NJ 1988; 273–406
   Google Scholar